InvestmentJul 28, 2026, 08:08 AM
Enlivex Announces $400M Private Placement at Premium Prices
AI Summary
Enlivex Ltd. announced a private placement agreement with a single institutional investor to raise approximately $400,000,000. The shares will be issued at $5.00 per share for USD-funded subscriptions (17.4% premium) or $6.00 per share for RAIN token-funded subscriptions (40.8% premium), with the investor electing to use RAIN tokens. Proceeds will support the company's treasury strategy built around the Rain protocol and advance its clinical-stage immunotherapy, Allocetra™. The agreement also grants Enlivex an option to raise an additional $400,000,000 from the same investor over 36 months, subject to shareholder approval.
Key Highlights
- Enlivex announced a private placement to raise approximately $400,000,000.
- Shares are priced at $5.00 for USD/USDT/USD Coin, representing a 17.4% premium.
- Shares are priced at $6.00 for RAIN tokens, representing a 40.8% premium.
- The institutional investor has elected to fund the purchase using RAIN tokens.
- Net proceeds will fund the treasury strategy around the Rain protocol and Allocetra™ development.
- Enlivex has an option to require the investor to purchase an additional $400,000,000 over 36 months.
- Closing of the transaction is subject to shareholder approval.
Price Impact
More from ENLV